{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:40:03Z","timestamp":1790887203360,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T00:00:00Z","timestamp":1548288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T00:00:00Z","timestamp":1548288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000025","name":"U.S. Department of Health &amp; Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01 DK015556"],"award-info":[{"award-number":["R01 DK015556"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["RG 4853A3\/2"],"award-info":[{"award-number":["RG 4853A3\/2"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health &amp; Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01 NS081141-01A1"],"award-info":[{"award-number":["R01 NS081141-01A1"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Pharmaceutical agents currently approved for the treatment of multiple sclerosis reduce relapse rates, but do not reverse or prevent neurodegeneration nor initiate myelin repair. The highly selective estrogen receptor (ER) \u03b2 ligand chloroindazole (IndCl) shows particular promise promoting both remyelination while reducing inflammatory cytokines in the central nervous system of mice with experimental autoimmune encephalomyelitis. To optimize these benefits, we developed and screened seven novel IndCl analogues for their efficacy in promoting primary oligodendrocyte (OL) progenitor cell survival, proliferation, and differentiation\n                    <jats:italic>in vitro<\/jats:italic>\n                    by immunohistochemistry. Two analogues, IndCl-\n                    <jats:italic>o<\/jats:italic>\n                    -chloro and IndCl-\n                    <jats:italic>o<\/jats:italic>\n                    -methyl, induced proliferation and differentiation equivalent to IndCl and were selected for subsequent\n                    <jats:italic>in vivo<\/jats:italic>\n                    evaluation for their impact on clinical disease course, white matter pathology, and inflammation. Both compounds ameliorated disease severity, increased mature OLs, and improved overall myelination in the corpus callosum and white matter tracts of the spinal cord. These effects were accompanied by reduced production of the OL toxic molecules interferon-\u03b3 and chemokine (C-X-C motif) ligand, CXCL10 by splenocytes with no discernable effect on central nervous system-infiltrating leukocyte numbers, while IndCl-\n                    <jats:italic>o<\/jats:italic>\n                    -methyl also reduced peripheral interleukin (IL)\u221217. In addition, expression of the chemokine CXCL1, which is associated with developmental oligodendrogenesis, was upregulated by IndCl and both analogues. Furthermore, callosal compound action potential recordings from analogue-treated mice demonstrated a larger N1 component amplitude compared to vehicle, suggesting more functionally myelinated fibers. Thus, the\n                    <jats:italic>o<\/jats:italic>\n                    -Methyl and\n                    <jats:italic>o<\/jats:italic>\n                    -Chloro IndCl analogues represent a class of ER\u03b2 ligands that offer significant remyelination and neuroprotection as well as modulation of the immune system; hence, they appear appropriate to consider further for therapeutic development in multiple sclerosis and other demyelinating diseases.\n                  <\/jats:p>","DOI":"10.1038\/s41598-018-37420-x","type":"journal-article","created":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T06:05:12Z","timestamp":1548309912000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Analogues of ER\u03b2 ligand chloroindazole exert immunomodulatory and remyelinating effects in a mouse model of multiple sclerosis"],"prefix":"10.1038","volume":"9","author":[{"given":"Hawra","family":"Karim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelli","family":"Lauderdale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Lapato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelley","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Yasui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Yamate-Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Sekyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Katzenellenbogen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema K.","family":"Tiwari-Woodruff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,24]]},"reference":[{"key":"37420_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pathophys.2010.04.004","volume":"18","author":"A Denic","year":"2011","unstructured":"Denic, A. et al. The relevance of animal models in multiple sclerosis research. Pathophysiology 18, 21\u201329, https:\/\/doi.org\/10.1016\/j.pathophys.2010.04.004 (2011).","journal-title":"Pathophysiology"},{"key":"37420_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.clim.2011.04.005","volume":"142","author":"B Barun","year":"2012","unstructured":"Barun, B. & Bar-Or, A. Treatment of multiple sclerosis with anti-CD20 antibodies. Clin Immunol 142, 31\u201337, https:\/\/doi.org\/10.1016\/j.clim.2011.04.005 (2012).","journal-title":"Clin Immunol"},{"key":"37420_CR3","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.4049\/jimmunol.155.8.4052","volume":"155","author":"DJ Cua","year":"1995","unstructured":"Cua, D. J., Hinton, D. R. & Stohlman, S. A. Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. Th2-mediated suppression of autoimmune disease. J Immunol 155, 4052\u20134059 (1995).","journal-title":"J Immunol"},{"key":"37420_CR4","doi-asserted-by":"publisher","first-page":"4477","DOI":"10.2741\/3543","volume":"14","author":"A Nicot","year":"2009","unstructured":"Nicot, A. Gender and sex hormones in multiple sclerosis pathology and therapy. Front Biosci 14, 4477\u20134515 (2009).","journal-title":"Front Biosci"},{"key":"37420_CR5","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1212\/WNL.52.6.1230","volume":"52","author":"S Kim","year":"1999","unstructured":"Kim, S., Liva, S. M., Dalal, M. A., Verity, M. A. & Voskuhl, R. R. Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis. Neurology 52, 1230\u20131238 (1999).","journal-title":"Neurology"},{"key":"37420_CR6","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s000110050332","volume":"47","author":"L Jansson","year":"1998","unstructured":"Jansson, L. & Holmdahl, R. Estrogen-mediated immunosuppression in autoimmune diseases. Inflamm Res 47, 290\u2013301 (1998).","journal-title":"Inflamm Res"},{"key":"37420_CR7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/aje\/kwp113","volume":"170","author":"E Banks","year":"2009","unstructured":"Banks, E. & Canfell, K. Invited Commentary: Hormone therapy risks and benefits\u2013The Women\u2019s Health Initiative findings and the postmenopausal estrogen timing hypothesis. Am J Epidemiol 170, 24\u201328, https:\/\/doi.org\/10.1093\/aje\/kwp113 (2009).","journal-title":"Am J Epidemiol"},{"key":"37420_CR8","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s00204-012-0868-5","volume":"86","author":"KA Burns","year":"2012","unstructured":"Burns, K. A. & Korach, K. S. Estrogen receptors and human disease: an update. Arch Toxicol 86, 1491\u20131504, https:\/\/doi.org\/10.1007\/s00204-012-0868-5 (2012).","journal-title":"Arch Toxicol"},{"key":"37420_CR9","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1021\/jm049223g","volume":"48","author":"M De Angelis","year":"2005","unstructured":"De Angelis, M., Stossi, F., Carlson, K. A., Katzenellenbogen, B. S. & Katzenellenbogen, J. A. Indazole Estrogens:\u2009 Highly Selective Ligands for the Estrogen Receptor \u03b2. Journal of Medicinal Chemistry 48, 1132\u20131144, https:\/\/doi.org\/10.1021\/jm049223g (2005).","journal-title":"Journal of Medicinal Chemistry"},{"key":"37420_CR10","doi-asserted-by":"publisher","first-page":"18061","DOI":"10.1073\/pnas.1411294111","volume":"111","author":"SM Moore","year":"2014","unstructured":"Moore, S. M. et al. Multiple functional therapeutic effects of the estrogen receptor beta agonist indazole-Cl in a mouse model of multiple sclerosis. Proc Natl Acad Sci USA 111, 18061\u201318066, https:\/\/doi.org\/10.1073\/pnas.1411294111 (2014).","journal-title":"Proc Natl Acad Sci USA"},{"key":"37420_CR11","doi-asserted-by":"publisher","unstructured":"Karim, H. et al. Increase in chemokine CXCL1 by ERbeta ligand treatment is a key mediator in promoting axon myelination. Proc Natl Acad Sci USA, https:\/\/doi.org\/10.1073\/pnas.1721732115 (2018).","DOI":"10.1073\/pnas.1721732115"},{"key":"37420_CR12","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.cell.2011.03.050","volume":"145","author":"K Saijo","year":"2011","unstructured":"Saijo, K., Collier, J. G., Li, A. C., Katzenellenbogen, J. A. & Glass, C. K. An ADIOL-ERbeta-CtBP transrepression pathway negatively regulates microglia-mediated inflammation. Cell 145, 584\u2013595, https:\/\/doi.org\/10.1016\/j.cell.2011.03.050 (2011).","journal-title":"Cell"},{"key":"37420_CR13","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/med.20186","volume":"31","author":"F Minutolo","year":"2011","unstructured":"Minutolo, F., Macchia, M., Katzenellenbogen, B. S. & Katzenellenbogen, J. A. Estrogen receptor beta ligands: recent advances and biomedical applications. Med Res Rev 31, 364\u2013442, https:\/\/doi.org\/10.1002\/med.20186 (2011).","journal-title":"Med Res Rev"},{"key":"37420_CR14","doi-asserted-by":"publisher","first-page":"19125","DOI":"10.1073\/pnas.1311763110","volume":"110","author":"AJ Khalaj","year":"2013","unstructured":"Khalaj, A. J. et al. Estrogen receptor (ER) beta expression in oligodendrocytes is required for attenuation of clinical disease by an ERbeta ligand. Proc Natl Acad Sci USA 110, 19125\u201319130, https:\/\/doi.org\/10.1073\/pnas.1311763110 (2013).","journal-title":"Proc Natl Acad Sci USA"},{"key":"37420_CR15","doi-asserted-by":"publisher","unstructured":"Paterni, I., Granchi, C., Katzenellenbogen, J. A. & Minutolo, F. Estrogen receptors alpha (ERalpha) and beta (ERbeta): subtype-selective ligands and clinical potential. Steroids 90, 13\u201329, https:\/\/doi.org\/10.1016\/j.steroids.2014.06.012 S0039-128X(14)00151-2 [pii] (2014).","DOI":"10.1016\/j.steroids.2014.06.012"},{"key":"37420_CR16","doi-asserted-by":"publisher","first-page":"271ra279","DOI":"10.1126\/scitranslmed.3010626","volume":"7","author":"Y Zhao","year":"2015","unstructured":"Zhao, Y. et al. Dual suppression of estrogenic and inflammatory activities for targeting of endometriosis. Sci Transl Med 7, 271ra279, https:\/\/doi.org\/10.1126\/scitranslmed.3010626 (2015).","journal-title":"Sci Transl Med"},{"key":"37420_CR17","doi-asserted-by":"publisher","unstructured":"Schildge, S., Bohrer, C., Beck, K. & Schachtrup, C. Isolation and culture of mouse cortical astrocytes. J Vis Exp, https:\/\/doi.org\/10.3791\/50079 (2013).","DOI":"10.3791\/50079"},{"key":"37420_CR18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1750-3639.2010.00444.x","volume":"21","author":"M Mangiardi","year":"2011","unstructured":"Mangiardi, M. et al. An animal model of cortical and callosal pathology in multiple sclerosis. Brain Pathol 21, 263\u2013278, https:\/\/doi.org\/10.1111\/j.1750-3639.2010.00444.x (2011).","journal-title":"Brain Pathol"},{"key":"37420_CR19","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/brb3.174","volume":"3","author":"S Moore","year":"2013","unstructured":"Moore, S. et al. Therapeutic laquinimod treatment decreases inflammation, initiates axon remyelination, and improves motor deficit in a mouse model of multiple sclerosis. Brain Behav 3, 664\u2013682, https:\/\/doi.org\/10.1002\/brb3.174 (2013).","journal-title":"Brain Behav"},{"key":"37420_CR20","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1093\/brain\/awq237","volume":"133","author":"DK Crawford","year":"2010","unstructured":"Crawford, D. K. et al. Oestrogen receptor beta ligand: a novel treatment to enhance endogenous functional remyelination. Brain 133, 2999\u20133016, https:\/\/doi.org\/10.1093\/brain\/awq237 (2010).","journal-title":"Brain"},{"key":"37420_CR21","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.neuroscience.2013.04.017","volume":"245","author":"S Moore","year":"2013","unstructured":"Moore, S., Patel, R., Hannsun, G., Yang, J. & Tiwari-Woodruff, S. K. Sex chromosome complement influences functional callosal myelination. Neuroscience 245, 166\u2013178, https:\/\/doi.org\/10.1016\/j.neuroscience.2013.04.017 (2013).","journal-title":"Neuroscience"},{"key":"37420_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jneumeth.2009.05.013","volume":"182","author":"DK Crawford","year":"2009","unstructured":"Crawford, D. K., Mangiardi, M. & Tiwari-Woodruff, S. K. Assaying the functional effects of demyelination and remyelination: revisiting field potential recordings. J Neurosci Methods 182, 25\u201333, https:\/\/doi.org\/10.1016\/j.jneumeth.2009.05.013 (2009).","journal-title":"J Neurosci Methods"},{"key":"37420_CR23","first-page":"65","volume":"108","author":"S Tiwari-Woodruff","year":"2009","unstructured":"Tiwari-Woodruff, S., Crawford, D., Song, B., Sofroniew, M. & Mangiardi, M. A critical window: functional recovery of callosal axons following demyelination. Journal of Neurochemistry 108, 65\u201366 (2009).","journal-title":"Journal of Neurochemistry"},{"key":"37420_CR24","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1083\/jcb.153.2.295","volume":"153","author":"SK Tiwari-Woodruff","year":"2001","unstructured":"Tiwari-Woodruff, S. K. et al. OSP\/claudin-11 forms a complex with a novel member of the tetraspanin super family and beta1 integrin and regulates proliferation and migration of oligodendrocytes. J Cell Biol 153, 295\u2013305 (2001).","journal-title":"J Cell Biol"},{"key":"37420_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1085\/jgp.115.2.123","volume":"115","author":"SK Tiwari-Woodruff","year":"2000","unstructured":"Tiwari-Woodruff, S. K., Lin, M. A., Schulteis, C. T. & Papazian, D. M. Voltage-dependent structural interactions in the Shaker K(+) channel. J Gen Physiol 115, 123\u2013138 (2000).","journal-title":"J Gen Physiol"},{"key":"37420_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jneumeth.2017.04.003","volume":"284","author":"JPC Hasselmann","year":"2017","unstructured":"Hasselmann, J. P. C., Karim, H., Khalaj, A. J., Ghosh, S. & Tiwari-Woodruff, S. K. Consistent induction of chronic experimental autoimmune encephalomyelitis in C57BL\/6 mice for the longitudinal study of pathology and repair. J Neurosci Methods 284, 71\u201384, https:\/\/doi.org\/10.1016\/j.jneumeth.2017.04.003 (2017).","journal-title":"J Neurosci Methods"},{"key":"37420_CR27","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.nbd.2013.04.005","volume":"56","author":"S Kumar","year":"2013","unstructured":"Kumar, S. et al. Estrogen receptor beta ligand therapy activates PI3K\/Akt\/mTOR signaling in oligodendrocytes and promotes remyelination in a mouse model of multiple sclerosis. Neurobiol Dis 56, 131\u2013144, https:\/\/doi.org\/10.1016\/j.nbd.2013.04.005 (2013).","journal-title":"Neurobiol Dis"},{"key":"37420_CR28","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/eji.201040796","volume":"41","author":"S Du","year":"2011","unstructured":"Du, S., Sandoval, F., Trinh, P., Umeda, E. & Voskuhl, R. Estrogen receptor-beta ligand treatment modulates dendritic cells in the target organ during autoimmune demyelinating disease. Eur J Immunol 41, 140\u2013150, https:\/\/doi.org\/10.1002\/eji.201040796 (2011).","journal-title":"Eur J Immunol"},{"key":"37420_CR29","first-page":"A316","volume":"68","author":"SK Tiwari-Woodruff","year":"2007","unstructured":"Tiwari-Woodruff, S. K., Morales, L.-B. J., Lee, R. & Voskuhl, R. Differential effects of estrogen receptor (ER) alpha versus ER beta ligand treatment: Anti-inflammatory versus directly neuroprotective. Neurology 68, A316\u2013A316 (2007).","journal-title":"Neurology"},{"key":"37420_CR30","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1530\/rep.0.1250143","volume":"125","author":"SC Hewitt","year":"2003","unstructured":"Hewitt, S. C. & Korach, K. S. Oestrogen receptor knockout mice: roles for oestrogen receptors alpha and beta in reproductive tissues. Reproduction 125, 143\u2013149 (2003).","journal-title":"Reproduction"},{"key":"37420_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2010.04143.x","volume":"162","author":"JM Fletcher","year":"2010","unstructured":"Fletcher, J. M., Lalor, S. J., Sweeney, C. M., Tubridy, N. & Mills, K. H. T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol 162, 1\u201311, https:\/\/doi.org\/10.1111\/j.1365-2249.2010.04143.x (2010).","journal-title":"Clin Exp Immunol"},{"key":"37420_CR32","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1517\/14712598.4.12.1887","volume":"4","author":"RB Moss","year":"2004","unstructured":"Moss, R. B. et al. Th1\/Th2 cells in inflammatory disease states: therapeutic implications. Expert Opin Biol Ther 4, 1887\u20131896, https:\/\/doi.org\/10.1517\/14712598.4.12.1887 (2004).","journal-title":"Expert Opin Biol Ther"},{"key":"37420_CR33","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1146\/annurev-immunol-031210-101312","volume":"29","author":"W Ouyang","year":"2011","unstructured":"Ouyang, W., Rutz, S., Crellin, N. K., Valdez, P. A. & Hymowitz, S. G. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol 29, 71\u2013109, https:\/\/doi.org\/10.1146\/annurev-immunol-031210-101312 (2011).","journal-title":"Annu Rev Immunol"},{"key":"37420_CR34","doi-asserted-by":"publisher","unstructured":"Tirotta, E., Ransohoff, R. M. & Lane, T. E. CXCR2 signaling protects oligodendrocyte progenitor cells from IFN-gamma\/CXCL10-mediated apoptosis. Glia 59, 1518\u20131528, https:\/\/doi.org\/10.1002\/glia.21195 Epub 2011 Jun 8. (2011).","DOI":"10.1002\/glia.21195"},{"key":"37420_CR35","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/glia.20246","volume":"53","author":"KM Omari","year":"2006","unstructured":"Omari, K. M., John, G., Lango, R. & Raine, C. S. Role for CXCR2 and CXCL1 on glia in multiple sclerosis. Glia 53, 24\u201331 (2006).","journal-title":"Glia"},{"key":"37420_CR36","doi-asserted-by":"publisher","first-page":"H191","DOI":"10.1152\/ajpheart.01012.2013","volume":"307","author":"B Xue","year":"2014","unstructured":"Xue, B. et al. Estrogen regulation of the brain renin-angiotensin system in protection against angiotensin II-induced sensitization of hypertension. Am J Physiol Heart Circ Physiol 307, H191\u2013198, https:\/\/doi.org\/10.1152\/ajpheart.01012.2013 (2014).","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"37420_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/glia.20582","volume":"56","author":"R Filipovic","year":"2008","unstructured":"Filipovic, R. & Zecevic, N. The effect of CXCL1 on human fetal oligodendrocyte progenitor cells. Glia 56, 1\u201315, https:\/\/doi.org\/10.1002\/glia.20582 (2008).","journal-title":"Glia"},{"key":"37420_CR38","doi-asserted-by":"publisher","first-page":"10095","DOI":"10.1074\/jbc.273.17.10095","volume":"273","author":"JR White","year":"1998","unstructured":"White, J. R. et al. Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration. Journal of Biological Chemistry 273, 10095\u201310098, https:\/\/doi.org\/10.1074\/jbc.273.17.10095 (1998).","journal-title":"Journal of Biological Chemistry"},{"key":"37420_CR39","doi-asserted-by":"publisher","unstructured":"Ozturk, A. et al. MRI of the corpus callosum in multiple sclerosis: association with disability. Mult Scler 16, 166\u2013177, https:\/\/doi.org\/10.1177\/1352458509353649 16\/2\/166 [pii] (2010).","DOI":"10.1177\/1352458509353649"},{"key":"37420_CR40","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.neuroscience.2009.09.069","volume":"164","author":"DK Crawford","year":"2009","unstructured":"Crawford, D. K., Mangiardi, M., Xia, X., Lopez-Valdes, H. E. & Tiwari-Woodruff, S. K. Functional recovery of callosal axons following demyelination: a critical window. Neuroscience 164, 1407\u20131421, https:\/\/doi.org\/10.1016\/j.neuroscience.2009.09.069 (2009).","journal-title":"Neuroscience"},{"key":"37420_CR41","unstructured":"Paxinos, G. & Franklin, K. B. J. The Mouse Brain in Stereotaxic Coordinates. (Elsevier Academic Press 2004)."},{"key":"37420_CR42","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/0014-4886(83)90044-4","volume":"79","author":"RJ Preston","year":"1983","unstructured":"Preston, R. J., Waxman, S. G. & Kocsis, J. D. Effects of 4-aminopyridine on rapidly and slowly conducting axons of rat corpus callosum. Exp Neurol 79, 808\u2013820 (1983).","journal-title":"Exp Neurol"},{"key":"37420_CR43","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1023\/A:1022586726510","volume":"24","author":"B Popko","year":"1999","unstructured":"Popko, B. & Baerwald, K. D. Oligodendroglial response to the immune cytokine interferon gamma. Neurochem Res 24, 331\u2013338 (1999).","journal-title":"Neurochem Res"},{"key":"37420_CR44","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1007\/BF03401888","volume":"1","author":"T Vartanian","year":"1995","unstructured":"Vartanian, T., Li, Y., Zhao, M. & Stefansson, K. Interferon-gamma-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. Mol Med 1, 732\u2013743 (1995).","journal-title":"Mol Med"},{"key":"37420_CR45","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/0165-5728(93)90244-S","volume":"46","author":"A Noronha","year":"1993","unstructured":"Noronha, A., Toscas, A. & Jensen, M. A. Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis. J Neuroimmunol 46, 145\u2013153 (1993).","journal-title":"J Neuroimmunol"},{"key":"37420_CR46","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1073\/pnas.94.2.599","volume":"94","author":"KE Balashov","year":"1997","unstructured":"Balashov, K. E., Smith, D. R., Khoury, S. J., Hafler, D. A. & Weiner, H. L. Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+\u2009T cells via CD40 ligand. Proc Natl Acad Sci USA 94, 599\u2013603 (1997).","journal-title":"Proc Natl Acad Sci USA"},{"key":"37420_CR47","doi-asserted-by":"publisher","unstructured":"Sosa, R. A., Murphey, C., Robinson, R. R. & Forsthuber, T. G. IFN-gamma ameliorates autoimmune encephalomyelitis by limiting myelin lipid peroxidation. Proc Natl Acad Sci USA 112, E5038\u20135047, https:\/\/doi.org\/10.1073\/pnas.1505955112 Epub2015 Aug 24 (2015).","DOI":"10.1073\/pnas.1505955112"},{"key":"37420_CR48","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1523\/Jneurosci.4689-06.2007","volume":"27","author":"R Balabanov","year":"2007","unstructured":"Balabanov, R. et al. Interferon-gamma-oligodendrocyte interactions in the regulation of experimental autoimmune encephalomyelitis. Journal of Neuroscience 27, 2013\u20132024, https:\/\/doi.org\/10.1523\/Jneurosci.4689-06.2007 (2007).","journal-title":"Journal of Neuroscience"},{"key":"37420_CR49","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1191\/135245899678846230","volume":"5","author":"PS Sorensen","year":"1999","unstructured":"Sorensen, P. S. Biological markers in body fluids for activity and progression in multiple sclerosis. Mult Scler 5, 287\u2013290 (1999).","journal-title":"Mult Scler"},{"key":"37420_CR50","doi-asserted-by":"publisher","first-page":"7617","DOI":"10.4049\/jimmunol.166.12.7617","volume":"166","author":"BT Fife","year":"2001","unstructured":"Fife, B. T. et al. CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+\u2009T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis. J Immunol 166, 7617\u20137624 (2001).","journal-title":"J Immunol"},{"key":"37420_CR51","doi-asserted-by":"publisher","first-page":"4308","DOI":"10.4049\/jimmunol.180.6.4308","volume":"180","author":"K De Filippo","year":"2008","unstructured":"De Filippo, K., Henderson, R. B., Laschinger, M. & Hogg, N. Neutrophil chemokines KC and macrophage-inflammatory protein-2 are newly synthesized by tissue macrophages using distinct TLR signaling pathways. Journal of Immunology 180, 4308\u20134315, https:\/\/doi.org\/10.4049\/jimmunol.180.6.4308 (2008).","journal-title":"Journal of Immunology"},{"key":"37420_CR52","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S0092-8674(02)00838-3","volume":"110","author":"HH Tsai","year":"2002","unstructured":"Tsai, H. H. et al. The chemokine receptor CXCR2 controls positioning of oligodendrocyte precursors in developing spinal cord by arresting their migration. Cell 110, 373\u2013383 (2002).","journal-title":"Cell"},{"key":"37420_CR53","doi-asserted-by":"publisher","first-page":"10457","DOI":"10.1523\/JNEUROSCI.18-24-10457.1998","volume":"18","author":"S Robinson","year":"1998","unstructured":"Robinson, S., Tani, M., Strieter, R. M., Ransohoff, R. M. & Miller, R. H. The chemokine growth-regulated oncogene-alpha promotes spinal cord oligodendrocyte precursor proliferation. J Neurosci 18, 10457\u201310463 (1998).","journal-title":"J Neurosci"},{"key":"37420_CR54","doi-asserted-by":"crossref","unstructured":"Omari, K. M., Lutz, S. E., Santambrogio, L., Lira, S. A. & Raine, C. S. Neuroprotection and remyelination after autoimmune demyelination in mice that inducibly overexpress CXCL1. Am J Pathol 174, 164\u2013176, S0002-9440(10)61275-8 [pii] 10.2353\/ajpath.2009.080350 (2009).","DOI":"10.2353\/ajpath.2009.080350"},{"key":"37420_CR55","doi-asserted-by":"publisher","first-page":"4553","DOI":"10.4049\/jimmunol.1700263","volume":"198","author":"CC Lin","year":"2017","unstructured":"Lin, C. C. & Edelson, B. T. New Insights into the Role of IL-1beta in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis. J Immunol 198, 4553\u20134560, https:\/\/doi.org\/10.4049\/jimmunol.1700263 (2017).","journal-title":"J Immunol"},{"key":"37420_CR56","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","volume":"117","author":"CA Dinarello","year":"2011","unstructured":"Dinarello, C. A. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 117, 3720\u20133732, https:\/\/doi.org\/10.1182\/blood-2010-07-273417 (2011).","journal-title":"Blood"},{"key":"37420_CR57","doi-asserted-by":"publisher","first-page":"7046","DOI":"10.1523\/JNEUROSCI.21-18-07046.2001","volume":"21","author":"JL Mason","year":"2001","unstructured":"Mason, J. L., Suzuki, K., Chaplin, D. D. & Matsushima, G. K. Interleukin-1beta promotes repair of the CNS. J Neurosci 21, 7046\u20137052 (2001).","journal-title":"J Neurosci"},{"key":"37420_CR58","doi-asserted-by":"publisher","first-page":"519627","DOI":"10.1155\/2013\/519627","volume":"2013","author":"SF Zorzella-Pezavento","year":"2013","unstructured":"Zorzella-Pezavento, S. F. et al. Persistent inflammation in the CNS during chronic EAE despite local absence of IL-17 production. Mediators Inflamm 2013, 519627, https:\/\/doi.org\/10.1155\/2013\/519627 (2013).","journal-title":"Mediators Inflamm"},{"key":"37420_CR59","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.molmed.2016.01.001","volume":"22","author":"A Beringer","year":"2016","unstructured":"Beringer, A., Noack, M. & Miossec, P. IL-17 in Chronic Inflammation: From Discovery to Targeting. Trends Mol Med 22, 230\u2013241, https:\/\/doi.org\/10.1016\/j.molmed.2016.01.001 (2016).","journal-title":"Trends Mol Med"},{"key":"37420_CR60","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.cytogfr.2014.07.013","volume":"25","author":"DW Luchtman","year":"2014","unstructured":"Luchtman, D. W., Ellwardt, E., Larochelle, C. & Zipp, F. IL-17 and related cytokines involved in the pathology and immunotherapy of multiple sclerosis: Current and future developments. Cytokine Growth Factor Rev 25, 403\u2013413, https:\/\/doi.org\/10.1016\/j.cytogfr.2014.07.013 (2014).","journal-title":"Cytokine Growth Factor Rev"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37420-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37420-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37420-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:21:20Z","timestamp":1694564480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37420-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,24]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["37420"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-37420-x","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.734925041.793562460","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,24]]},"assertion":[{"value":"5 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"503"}}